It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The repair of articular cartilage after damage is challenging, and decellularized tissue offers a possible treatment option to promote regeneration. Here, we show that acellular osteochondral allografts improve integrative cartilage repair compared to untreated defects after 6 months in an ovine model. Functional measures of intratissue strain/structure assessed by MRI demonstrate similar biomechanics of implants and native cartilage. Compared to native tissue and defects, the structure, composition, and tribology of acellular allografts preserve surface roughness and lubrication, material properties under compression and relaxation, compositional ratios of collagen:glycosaminoglycan and collagen:phosphate, and relative composition of types I/II collagen. While high cellularity was observed in bone regions and integration zones between cartilage-allografts, recellularization of chondral implants was inconsistent, with cell migration typically less than ~750 µm into the dense decellularized tissue, possibly limiting long-term cellular maintenance. Our results demonstrate the structural and biomechanical efficacy of acellular allografts for at least six months in vivo.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Colorado Boulder, Department of Mechanical Engineering, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564)
2 Purdue University, Weldon School of Biomedical Engineering, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197)
3 University of Colorado Boulder, Biomedical Engineering Program, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564)
4 University of Colorado Boulder, Department of Mechanical Engineering, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564); University of Colorado Boulder, Biomedical Engineering Program, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564); University of Colorado Boulder, BioFrontiers Institute, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564)
5 University of Colorado Boulder, Department of Ecology and Evolutionary Biology, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564)
6 Purdue University, Department of Veterinary Clinical Services, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197)
7 University of Colorado Boulder, Department of Mechanical Engineering, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564); Purdue University, Weldon School of Biomedical Engineering, West Lafayette, USA (GRID:grid.169077.e) (ISNI:0000 0004 1937 2197); University of Colorado Boulder, Biomedical Engineering Program, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564); University of Colorado Boulder, BioFrontiers Institute, Boulder, USA (GRID:grid.266190.a) (ISNI:0000 0000 9621 4564)